SCHEMBL8082082

SCHEMBL8082082

Cc1csc(S(=O)(=O)C2(c3cc(N)nc(-c4ccc(NC(=O)NC5CC5)cc4)n3)CCCC2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 3/20 0.38
MTOR P42345 3/20 0.38
KDR P35968 3/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
KLKB1 P03952 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
RAB9A P51151 4/20 0.35
EPHX1 P07099 3/20 0.35
NPC1 O15118 3/20 0.35
GAA P10253 1/20 0.35
EPHX2 P34913 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8089090 0.95 KDR (0.39) PIK3CAMTORKDRMEN1KMT2A
SCHEMBL8090804 0.87 MTOR (0.37) PIK3CAMTORKDRKMT2ARAB9A
SCHEMBL8085149 0.85 PIK3CA (0.39) PIK3CAMTORKDRKDM4EALDH1A1
SCHEMBL8097954 0.83 MAPK1 (0.33) PIK3CAKDRCA12CA1CA2
SCHEMBL8093434 0.83 PIK3CD (0.35) PIK3CARAB9A
SCHEMBL8091977 0.83 PIK3CD (0.35) PIK3CAALDH1A1RAB9AGAA
SCHEMBL8097960 0.83 KDM4E (0.38) PIK3CAMTORKDRMEN1KMT2A
SCHEMBL8084016 0.83 CA12 (0.41) PIK3CAMTORKDRMEN1KMT2A
SCHEMBL8098772 0.83 PIK3CD (0.39) PIK3CAMTORKDRMEN1KMT2A
SCHEMBL8089088 0.83 PIK3CA (0.40) PIK3CAMTORKDRKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed